Members of family
For successful infection, viruses must solve several problems and overcome barriers that would impede or prevent infection. Some of these barriers include finding a suitable host, circumventing the immune system, interacting with cells within their host range, attaching to the cell surface, penetrating to the interior of the cell and finding ways for transcription, synthesis of their gene products, genome replication, assembly of the particle components, and escape from the infected cell. As a whole, viruses are paradoxically, fascinatingly simple yet complex. Some viruses, such as those that are enveloped, enter the target cell by attacking the cell membrane with a fusion protein, or a fusion domain of an attachment protein, that invades the cell membrane and promotes fusion of the viral envelope with the cell membrane. This fusion event may occur either at the plasma membrane level or at a membrane site in the endocytic vesicle. The viral genome then is free of its envelope and can enter the cell interior. Nonenveloped viruses generally do not enter by fusion at the plasma membrane level but are commonly taken into the cell by endocytosis, then, by some mechanism, are able to invade the cell cytoplasm by escaping from confinement in the endosome. The pathways for virus entry along with the entry subtleties are nearly as diverse as the virus families themselves. Many of the parvoviruses are known to employ the clathrin-associated acid mediated endocytotic pathway for penetration into their host cell and this chapter deals with parvovirus entry.
The virus family
Most parvoviruses, as understood to date, utilize several different subtle variations of a general strategy to deliver their genome to the cell nucleus, the site of virus replication. These are late penetrating viruses, in the sense that they are pH-dependent and persist longer through the endocytic transport system than earlier penetrating viruses (Greber, 2011). The rugged, mature, extracellular virion undergoes multistep conformational changes that are time- and cell compartment-dependent. In general, several discrete steps have been recognized that entering parvoviruses follow. These are interaction with a cell surface receptor, trafficking through the endosomal pathway to the late endosome or lysosome, or through macropinocytosis for porcine parvovirus (Boisvert et al., 2010), escape from the endosomal pathway using the newly deployed phospholipase 2 (PLA2) domain of the capsid protein, and cytoskeletal-controlled transport of the modified particle to the nucleus.
Techniques employed in the laboratory for the elucidation of viral entry pathways involve both direct observational detection of virus in cells and indirect detection of virus movement by blocking specific functions in the process with chemical inhibitors. Electron microscopy is used as a method for showing virus associated with cell structures giving “snap shot” views of virus over time intervals in the entry process. Parvoviruses, for example, can be seen associated with clathrin coated pits and in endosomes (Dudleenamjil et al., 2010; Parker & Parrish, 2000; Vendeville et al., 2009). Chemical inhibitors are assumed to block the entry pathway at certain specific points and incomplete virus replication in the presence of inhibitor is presumed to indicate viral penetration using the pathway blocked by the drug. Commonly used drugs are chlorpromazine (prevents assembly and disassembly of clathrin lattices at the cell surface and on endosomes by inhibiting clathrin polymerization which blocks assembly of coated pits and is also a phospholipase A2 inhibitor, Blanchard et al., 2006); bafilamycin A1 (inhibits vacuolar proton ATPases inhibiting acidification of endosomes by blocking transport of protons into the vesicle, Clague et al., 1994; Drose & Altendorf, 1997; Wassmer et al., 2005); ammonium chloride (penetrates into the endosome increasing endosomal pH, Jin et al., 2002; Liebl et al., 2006); chloroquine (blocks assembly of clathrin coated pits and raises endosomal pH, Mani et al., 2006; Ros et al., 2002). Brefeldin A has no effect on the early endosome but inhibits vesicle transport and early-to-late endosome transition (Clague et al., 1994; Nebenfuhr et al., 2002).
Some drugs block virus entry through caveolae and can be used to help distinguish virus entry through caveolae or clathrin-associated endosomes. The antifungal drug nystatin complexes with and sequesters cholesterol inhibiting lipid rafts and caveolae (Chazal & Gerlier, 2003; Damm et al., 2005; Sieczkarski & Whittaker, 2002). Phorbol-12-myristate-13-acetate, a mitogen and a tumor promoter, decreases membrane caveolin-1 (Smart et al., 1994). Methyl-β-cyclodextrin disrupts detergent-resistant lipid rafts (Beer et al., 2005). Genistein blocks phosphorylation of tyrosine kinase which is involved in the formation of caveosomes (Pelkmans, 2005a). Other drugs block transport of virions (or modified virions) through the cell cytoplasm. Some viruses depend on microtubules for transport and some associate with actin filaments. Nocodazole blocks microtubule polymerization (Brandenburg & Zhuang, 2007; Pelkmans & Helenius, 2003), vanadate is a dynein inhibitor (Beckerle & Porter, 1982), erythro-9-3-(2hydroxynonyl)adenine also is a dynein inhibitor (Krietensson et al., 1986). Cytochalasin D disrupts actin microfilaments and blocks actin polymerization (Vendeville et al., 2009), and latrunculin A also inhibits actin polymerization (Damm et al., 2005; Forest et al., 2005).
There are some important concerns about the interpretation of the results obtained in studies that employ inhibitors. Concentrations of the drugs must be below the cell toxicity levels to preserve virus-dependent cell activities. In most cases complete shut-off of virus replication does not occur. So, the possibilities of pathway leakiness or the presence of more than one entrance pathway must be considered. None of the drugs possesses absolute specificity, therefore possible side effects may occur that affect interpretation. In studies like these, the use of several chemical inhibitors having different modes of action help to somewhat mitigate the problem of cloudy interpretation if the results are mutually supportive.
|Parvovirus||Gastroenteritis, cardiovascular failure|
|Enteric disease, cerebellar hypoplasia|
|Gastroenteritis, leukopenia, cerebellar hypoplasia|
|Gastroenteritis, anorexia, nasal discharge, death|
|Osteolytic infection, facial and tooth malformation|
|A hamster osteolytic virus|
|Viremia, ?other disease|
|Mostly asymptomatic, small litters, runting|
|Systemic infection in hamsters|
|Asymptomatic, MMVi is immunosuppressive|
|No known disease|
|Reproductive failure, embryonic death|
|Erythrovirus||Human parvovirus B19||Erythema infectiosum (Fifth disease), exanthema, hydrops fetalis|
|Bocavirus||Bovine parvovirus 1||Gastroenteritis (calf scours), dyspnea, stillborn calves|
|Bovine parvovirus 2||Same as BPV-1|
|Bovine parvovirus 3||Same as BPV-1|
|Canine minute virus||Diarrhea, anorexia, dyspnea|
|Human bocavirus||Upper respiratory, coryza|
|Amdovirus||Aleutian mink disease virus||Immune complex disease, glomerulonephritis, death|
|Dependovirus||Adeno-associated virus (types 1-11)||None known, latency in chromosome 19|
|Densovirus||Brevidensovirus||Infects mosquito larvae|
|Densovirus||GmDNV kills moth larvae|
|Iteravirus||Infects silkworm larvae|
|Pefudensovirus||Host is the cockroach|
Immunofluoresceinated virus particles have been used to show association of virus with cell receptors and clathrin-rich early endosomes (Freistadt & Eberle, 2006). Purified virus particles are directly labeled with the fluorescein fluor by treatment with N-hydroxysuccinimide-fluorescein. Attachment and uptake of virus by cells is tracked by flow cytometry, fluorescence microscopy, or confocal microscopy. Most viruses, including the very small parvoviruses, cannot be seen as individual particles by light microscopy, but clumps of viruses can be seen. Also, accumulated virus particles present in cell organelles such as late endosomes-lysosomes can be seen. Among the Rab proteins in cells, Rab5 is primarily associated with early endosomes, Rab7 with late endosomes, and Rab 11 with recycling endosomes. Co-localization of virus with specific Rab proteins provides evidence of virus trafficking through certain endosomal compartments.
A recent report provided cryoelectron microscopic images of the HBoV particle (Gurda et al., 2010). Other reports show the small, T=1 capsid of parvoviruses displays amino acid side chains to the inner capsid surface which bond to the bases of the single stranded genome (Agbandje-McKenna & Chapman, 2006; Chapman & Agbandje-McKenna, 2006). Such interactions occur as the genome is packaged into the preformed shell. Several features including the small size, compact capsid, interior molecular interactions, and lack of an envelope combine to make this virus remarkably environmentally stable. These viruses undergo several essential protein conformation shifts during the trafficking process but are able to remain essentially intact after attachment, engulfment, endosomal transit, travel through the cytoplasmic environment, association with the nuclear membrane, and travel across the nuclear membrane. Although there are some capsid alterations during this process (Cotmore & Tattersall, 2007), the viral genome remains capsid-associated as it enters the nuclear compartment.
2. Attachment of virus to the cell
Parvoviruses are known to utilize a variety of cell surface molecules as their receptors including glycoproteins, glycolipids, and glycans (Cotmore & Tattersall, 2007; Harbison et al., 2008). Members of the genus
The mammalian adeno-associated viruses (AAVs) have been extensively studied for use as gene vectors for therapy of diseases resulting from genetic defects. Cellular receptors and coreceptors are an area of crucial interest in viral vector-mediated gene therapy because receptor preference and receptor tissue distribution may dictate vector choice for a given organ. By understanding the mechanisms of viral entry into target cells it may be possible to manipulate the gene vector in order to target a cell type of interest. Heparan sulfate proteoglycan mediates attachment of AAV-2 to susceptible cell lines (Summerford & Samulski, 1998), and other cell entry receptors or co-receptors for AAV-2 include human fibroblast growth factor receptor-1 (FGFR-1) (Qing et al., 1999), αVβ5 integrin (Sanlioglu et al., 2000; Summerford et al., 1999), and hepatocyte growth factor receptor (c-Met) (Kashiwakura et al., 2005). It has been suggested that heparin sulfate may play a role in AAV-2 infection as a low affinity attachment molecule (Qiu et al., 2000). Reports indicate that a group of basic amino acids that contribute to heparin binding are clustered in three positions on the three-fold spike of the AAV-2 capsid (Kern et al., 2003). Additionally, AAV-5 reportedly binds to cell surface 2,3-linked sialic acids (Walters et al., 2001) and the AAV-5 receptor for hemagglutination and transduction is α2,3-N-linked sialic acid and that for AAV-4 is α2,3-O-linked sialic acid (Kaludov et al., 2001). AAV-5 also binds to the platelet derived growth factor receptor (Di Pasquale et al., 2003). AAV type 3 can use fibroblast growth factor receptor 1 for binding (Blackburn et al., 2006).
A characteristic feature of BPV is its ability to hemagglutinate erythrocytes, hence its original name, hemadsorbing enteric virus (HADEN) (Abinanti & Warfield, 1961). This aspect of virus-cell interaction is possible because this virus attaches to receptors on the red cell membrane. Glycophorin A is an abundant transmembrane glycoprotein found in the erythrocyte membrane (Tomita et al., 1978). The glycophorin A monomer is composed of a 131 amino acid sequence found in three domains that form the hydrophilic cytoplasmic domain, the hydrophobic transmembrane domain, and the aminoterminal glycosylated external domain. Glycophorin A naturally exists as a homodimer with extensive O-linked oligosaccharide glycosylation on the external domain. Exposure of the red cell surface to proteolytic enzymes or to neuraminidase destroyed the erythrocyte receptors for BPV indicating the receptor consists of a sialylglycoprotein (Thacker & Johnson, 1998). Virus probes on western blots and virus attachment to purified glycophorin A on dot blots confirmed virus attachment to this glycoprotein. Moreover, purified glycophorin A completely competed out virus attachment to the natural receptor. Further, Blackburn et al. (2005) showed BPV binding to α-2,3-linked sialic acid located on the O-linked oligosaccharides of the glycophorin A molecule. Treatment of glycophorin A with α2,3,-6,-8 neuraminidase eliminated binding of virus to this receptor. Beta-elimination of O-linked sialic acids on glycophorin A also eliminated binding while removal of N-linked carbohydrates using the N-glycosidase PNGase failed to eliminate virus binding. After enzymatic removal of the receptors, virus binding could be restored by reconstitution of the O-linked α2,3 neuraminic acids. On nucleated bovine host cells BPV attachment occurs on both α-2,3-O-linked and α-2,3-N-linked sialic acids (Johnson et al., 2004).
In studies on PPV infection, prior treatment of cells with neuraminidase prevented infection by eliminating PPV receptors (Boisvert et al., 2010). Resialation with α-2,3-
Host range is a property of the virus-host interaction that provides a suitable environment for complete virus replication resulting in the production of virus progeny. Only certain organs, tissues, and cells are within the host range of viruses. Commonly, host range is thought of relating to the availability of cell surface receptors. However, determination of host range and its resultant tissue tropism can occur at many levels including attachment to compatible receptors, the entry pathway, uncoating, the transcriptional environment, genome duplication, translational processes, assembly of virus particles, and mechanisms of escape from the host cell. At one level, host range for autonomous parvoviruses is determined by the viral requirement for S-phase cells. Frequently, in examples of parvovirus disease, the tissues involved are those which have an abundance of mitotic cells. In the case of FPV and CPV, related parvoviruses, attachment then entry by endocytosis can occur in many different kinds of non-permissive cells, indicating that their host range can be determined by events after cell entry. Amino acid residues 359 to 375 found in a flexible capsid protein loop were found to exhibit differential conformation when exposed to various concentrations of protons and Ca++ (Simpson et al., 2000). It was found that this region was functionally associated with both hemagglutinating activity and host range determinants providing continuance of successful replication.
Several possible pathways of receptor-mediated endocytosis are recognized: clathrin- and caveolae-mediated endocytosis, macropinocytosis, and novel nonclathrin/noncaveolae pathways (Brindley & Maury, 2008; Damm et al., 2005; Dimitrov, 2004; Kee et al., 2004; Marsh & Helenius, 2006; Meier & Greber, 2004; Meier et al., 2002; Mercer & Helenius, 2009; Pelkmans & Helenius, 2003; Pelkmans et al. 2004; Sieczkarski & Whittaker, 2002; Stuart & Brown, 2006). To date, for viral infections that have been studied, viruses mostly take advantage of clathrin-mediated endocytosis for internalization (Marsh & Helenius, 2006; Pelkmans & Helenius, 2003; Sieczkarski & Whittaker, 2002). During clathrin-mediated endocytosis, transport vesicles are surrounded by a clathrin coat, which is a three-dimensional array of triskelia. A triskelion is composed of three clathrin heavy chains (CHCs, approximately 190-kDa) and three light chains (CLCs, about 25-29 kDa), and has three-fold rotational symmetry (Edeling et al., 2006; Merrifield et al., 2005). Ligands that are to be transported to the cytosol, including viruses, are concentrated on the cell surface, and the concentrated ligands, as a patch, trigger recruitment of clathrin-adaptor proteins to the cytoplasmic side of the plasma membrane. Clathrin-adaptor complexes (APs) include the main distinct complexes, AP1 and AP2. A third protein, AP180, is used mainly for synaptic vesicles. The AP-2 complex consistes of α-adaptin, β2-adaptin, μ2-chain, and σ2-chain. APs bind to membranes by recognizing phosphoinositides and link clathrin to the membrane. Therefore, clathrin coated vesicles (CCVs) are three-layered: 1) the inner, membrane layer with its embedded receptor/ligand complex, 2) the middle layer that is composed of APs and other regulatory proteins for clathrin assembly, and 3) the outer clathrin shell (Edling et al., 2006). CCVs comprise one of the most common and well defined coated transport vesicles. The internal pH in the CCV is around 6.5. Once fission of the pit has occurred through the action of accessory proteins including dynamin and other proteins forming CCVs, the clathrin coat must be rapidly shed to allow fusion of the vesicle with its target membrane. Uncoating of clathrin is resolved by auxilin and the molecular chaperone Hsc70 (heat shock protein 70). Auxilin interacts with assembled clathrin and binds to Hsc70 via its carboxyl-terminal J domain triggering Hsc70’s ATPase activity. Hsc 70 then interrupts clathrin-clathrin interactions, causing shedding of the clathrin coat. Disassembled clathrin, accessory proteins and the endocytic recycling compartment (internal pH about 6.5) are recycled and promote the clathrin-coated vesicle cycle (Brandenburg & Zhuang, 2007; Dawsen et al., 2006; DeTulleo & Kirhchausen, 1998; Doxsey et al., 1987; Edling et al., 2006; Heuser & Anderson, 1989; Huang et al., 2004; Lemmon, 2001; Pu & Zhang, 2008; Sun et al., 2002). The cargo-containing vesicle then matures to the early endosome with an acidic environment (pH 6.5 to 6.0). In addition to the pH, markers for the early endosome include Rab5-GDP and Early Endosome Associated Protein-1. Virus-engaged receptors are uncoupled from their ligands at this mildly acidic environment of the early endosomes and ligand molecules are recycled back to the plasma membrane (Van der Goot & Gruenberg, 2006). The early endosomes are major sorting stations where the endosome is recycled back to the cell membrane, or where endocytosed cargo, including some viruses, can be released to the cytoplasm or can progress farther into the endosomal pathway to more acidic late endosomes (pH 6.0 to 5.0) and lysosomes. The acidification of endosomes is required for release of virus into the cytoplasm (Damm & Pelkmans, 2006; Gagescu et al., 2000; Lakadamyali et al., 2006; Marsh & Helenius, 2006; Pelkmans & Helenius, 2003; Russell et al., 2006; Sieczkarski & Whittaker, 2002; Smith & Helenius, 2004; Van der Goot & Gruenberg, 2006). The late endosome becomes a degradative body with lower pH. It acquires the marker for mannose-6-phosphate receptor (MPR+) and the Rab7-GDP marker. They also acquire the unusual lipid lysobisphosphatidic acid (LBPA).
After engulfment the genome or nucleocapsids of viruses are released into the cytosol by fusion of the viral envelope with the endosomal membrane for enveloped viruses or, for non-enveloped viruses, capsid disassembly occurs in the endosome for some viruses with subsequent genomic escape to the cytosol (Brandenburg et al., 2007; Stidwill & Greber, 2000). The acidic pH of endosomes plays an essential role to trigger these events. Further, some non-enveloped viruses begin the uncoating process in the late endosome, but complete uncoating is delayed and it is a nuclear event. For example, in some instances such as adenovirus, AAV and canine parvovirus infections, the genome together with modified capsid components translocate to the nuclear membrane (Meier & Greber, 2004; Sonntag et al., 2006; Vihinen-Ranta et al., 2002) where final uncoating occurs for adenovirus but the small parvovirus capsid crosses the nuclear membrane before final uncoating within the nucleus. Digestion of material enclosed in the late endosome may not be complete and fusion with lysosomes may occur forming a hybrid organelle with an internal pH of about 5.0 and are MPR-negative. Viruses that exploit clathrin-dependent acid-mediated entry are sensitive to the inhibitors of endosomal acidification. Thus, inhibition of virus replication by endosomal pH inhibitors is taken as evidence for virus tracking through an acid-mediated endocytosis pathway.
The transport of endosomes is mediated by microtubules and proceeds toward the microtubule organization center which is found in the perinuclear area of the cell. Thus, transport to the late endosomes/lysosomes is beneficial for both virion conformation adjustment and for transport to the nucleus. Once the virus has escaped from the endosomal compartment the virus particle itself may interact with microtubule motors or with actin filaments to complete the journey to the nuclear membrane. In the case of parvoviruses, proteosomal digestion can help or hinder virus infection. AAV particles are degraded by the proteosome causing an aborted infection (Douar et al., 2001) while proteosome processing is required for MVM infection (Ros et al., 2002).
Electron microscopic images of BPV-infected cells show vacuoles consistent with CCVs containing virus particles (Dudleenamjil et al., 2010) at 15 minutes post-infection. In a separate report on canine parvovirus (Parker & Parrish, 2000), virus particles were found in endosomes at 5 minutes and 15 minutes post-infection. Densonucleosis virus was shown by EM in CCVs of
In contrast to clathrin-mediated pH-dependent endocytosis, caveolae-mediated entry is an event triggered by binding of, for example, virus particles to receptor molecules on the cell surface that induces the clustering of lipid rafts with a high content of cholesterol and sphingolipids (Chazal & Gerlier, 2003; Hommelgaard et al., 2005; Pelkmans, 2005a). The area of the plasma membrane with the clusters invaginates to the cytosol, and the vesicle is surrounded by caveolins, the most characterized proteins of caveolae-mediated entry. These caveolin coated vesicles formed at the cholesterol-rich microdomains at the plasma membrane are the caveolae. Caveolins stabilize caveolae, and they are remarkably static in caveosomes (Marsh & Helenius, 2006; Pelkmans, 2005b). Accessory proteins involved in caveolae-mediated entry are dynamin and actin, and they are recruited by tyrosine kinase activites (Dimitrov, 2004; Marsh & Helenius, 2006; Pelkmans, 2005a; Pelkmans & Helenius, 2003; Pelkmans et al., 2005; Smith & Helenius, 2004). The caveolae containing the virus/receptor complex, close, pinch off from the cell membrane, and fuse together forming caveosomes. Caveosomes are part of the endocytic organelles with a neutral pH and the absence of markers for early, recycling, and late endosomes (Pelkmans, 2005a; Pelkmans & Helenius, 2003). Nevertheless, caveosomes connect with the smooth endoplasmic reticulum (ER), early and late endosomes, and the cell membrane. Release of virus taken up by the caveolar-raft system can occur from caveosomes (Echo 1), the ER (SV40), and endosomes (polyomaviruses and BK virus) (Eash et al., 2004; Marsh & Helenius, 2006; Pelkmans & Helenius, 2003). The interaction with endosomes may be crucial for some viruses that are taken up by caveolae-mediated endocytosis but require a low-pH environment for escape to the cytoplasm. Chemical inhibitors, targeted for a certain part of interconnected organelles of caveolae entry, are extensively exploited for examination of caveolae pathways used for virus entry. Results of studies utilizing inhibitors targeting caveolae found no evidence for BPV entry through these vesicles (Dudleenamjil et al., 2010) nor for PPV (Boisvert et al., 2010).
Active cell entry routes of some members of the Parvoviridae family have been described. Parvoviruses are known to utilize a variety of cell surface molecules as their receptor including glycoproteins (Blackburn et al., 2005; Thacker & Johnson, 1998), glycolipids, and glycans (Cotmore & Tattersall, 2007). It has been reported that parvoviruses with known cell entry routes enter into CCVs and establish successful infections (Basak & Compans, 1989; Cotmore & Tattersall, 2007; Harbison et al., 2008; Op De Beeck & Caillet-Fauquet, 1997; Parker & Parrish, 2000; Ros et al., 2002; Vendeville et al., 2009). Most studied for illumination of this process are MVM, CPV, PPV, DNV and AAV. Adeno-associated virus (AAV)’s entry into the host cell is mediated by clathrin coated pits and then routes to the late endosomes (Bartlett et al., 2000). The virus particles then escape to the cytoplasm where they are partially degraded by the proteasome and delivered to the nucleus for replication (Douar et al., 2001). The canine parvovirus, having used the transferrin receptor (TfR) for attachment (Parker et al., 2001), enters through the CCVs, and localizes in endosomes (Hueffer et al., 2004; Parker & Parrish, 2000; Vihinen-Ranta et al., 2002). Both CPV and FPV bind to TfR but species-specific binding controls host range. CPV binds to the filopodia of canine cells while FPV infects cats binding to the TfR on feline cells. FPV does not bind the canine TfR, does not infect dogs, or infect cultured canine cells (Harbison et al., 2009). Conversely, CPV can infect feline cells by binding to TfR on the cell body. Minute virus of mice (MVM)’s cell entry and following events in the cytoplasm were investigated analyzing the effects of drugs that interfere with the endosomal acidification and ubiquitin-proteasome activities. Results suggested that MVM’s entry is pH-dependent, and the interaction with the ubiquitin-proteasome system is required for MVM replication (Ros et al., 2002). The relatively rapid endocytic uptake of parvoviruses appears to be followed by slower traffic along the endocytic compartments toward the nucleus. The endosomal pathway undertaken by parvoviruses appears to be complex and depends on the virus, its concentration, and likely the cell type (Dorsch et al., 2002; Mani et al., 2006; Sonntag et al., 2006; Suikkanen et al., 2003; Yuan & Parrish, 2001). Conformational alterations in capsid structure probably occur in the endosomal compartment facilitating uncoating and transport to the nucleus.
The vacuolar proton ATPase (V-ATPase) is a multisubunit enzyme complex, and it is responsible for the acidification of membrane-bounded organelles like endosomes. V-ATPase transports H+ over membranes against an electrochemical potential under ATP hydrolysis, and H+ ions acidify endosomal environments. Baf A1 blocks the V-ATPase activity causing neutralization of the acidic environment of endosomes. Baf A1 is routinely used as a suppressor of V-ATPases, and it is used to test whether specific viral entry is reliant on endosomal acidification (Clague et al., 1994; Drose & Altendorf, 1997; Jin et al., 2005; Wassmer et al., 2005). It has been widely used as a probe to study acid-mediated viral trafficking using a variety of virus models. Entry pathway studies of mouse polyomavirus (Liebl et al., 2006), feline calicivirus (Stuart & Brown, 2006), bovine viral diarrhea virus (Lecot et al., 2005), AAV (Bartlett et al., 2000), MVM (Mani et al., 2006; Ros et al., 2002), mouse hepatitis virus type 2 (Pu & Zhang, 2008), poliovirus (Brandenburg et al., 2007), baculovirus (Long et al., 2006), hepatitis C virus (Blanchard et al., 2006), influenza virus (Guinea & Carrasco, 1995; Sieczkarski et al., 2003), HIV-1 (Fredericksen et al., 2002), and human rhinovirus 14 (Bayer et al., 1999) have analyzed the effects of Baf A1 on virus trafficking and examined the role of endosomal acidification in a route that leads to viral replication. For studies of parvovirus entry Baf A1 may be an inhibitor preferred over chlorpromazine because chlorpromazine is not only an inhibitor of clathrin lattice processing, but is also an inhibitor of phospholipase A2. Because parvoviruses use their own version of PLA2 for entry, confusion may arise regarding the point of inhibition.
4. Virus in the early endosome
In the process of acid mediated endocytosis acidification begins in the early endosome reaching a pH of 6.5 to 6.0. Proton transport continues during the transition to the late endosome which develops a pH of about 5.0 within this vesicle. The intravesicular environment of the lysosome is also characterized by low pH. Early endosomes are considered an initial sorting station where cargos for degradation are distinguished from those for recycling and this sorting process begins in clathrin coated vesicles, depends on microtubule motility, and appears to involve endocytosis adaptors (Lakadamyali et al., 2006). Acidification of endosomes is known to be essential for viruses which internalize within CCVs. Studies on parvovirus entry have reported that BPV, MVM, AAV, and CPV internalization require endosomal acidification, and the endosomal acidic environment may induce capsid conformational changes vital for viral release from endosomes to the cytoplasm (Basak & Compans, 1989; Douar et al., 2001; Dudleenamjil et al., 2010; Mani et al., 2006; Ros et al., 2002). Because the proton concentration increases during transition from early to late endosomes and high acidity is maintained in the lysosome, it is possible that acid-dependent uncoating of viruses, specifically pH-dependent capsid protein conformational shifts, may occur at various points within the early endosome, in the late endosome, or after exposure to the harsh environment in the lysosome complex.
The mechanisms of capsid endosomal processing in a low pH environment are poorly understood but are under investigation. The N termini of AAV VP1 and VP2 (VP1/VP2u), like the N terminus of MVM, CPV, and PPV VP1 (VP1u), contain motifs homologous to PLA2 and nuclear localization signals. AAV mutants that are consistent with a nuclear localization signal-deficient phenotype, traffick through the early endosome as the recombinant AAV2 control does, but forms a more diffuse accumulation pattern in the perinuclear area consistent with an NLS defect (Johnson et al., 2010). In a recent study, AAV-8 was exposed to pHs ranging from 7.5 to 4.0 and crystal structures of empty particles and green fluorescent protein gene-packaged particles were analyzed (Nam et al., 2011). The capsid surface topologies of particles exposed to various pHs were similar except changes located close to the two-fold depression and significant amino acid side chain conformational changes were seen on the interior surface of the capsid under the three-fold axis. The three-fold change is consistent with low pH-associated release of genomic DNA from an ordered state on the interior surface of the capsid and likely indicate capsid transitions that ultimately result in genome uncoating. The surface alteration results in disruption of VP-VP interface interactions along with a decrease in buried surface area between VP monomers. This destabilization may lead to activation of the PLA2 activity for endosomal escape and the NLS for nuclear targeting. As noted, it was observed by Nam et al. (2011) that at pH 4.0 specific interactions between the capsid and the packaged DNA genome are weakened but it is insufficient for genome uncoating. Rather, the intracapsid genome may be compacted. This process could be a step toward genome release or shift of the VP1u to externalization. These authors further point out that current thinking postulates that the five-fold pore of AAV is the externalization portal for the AAV VP1 and VP2 N-termini, the other parvovirus’ VP1u, and the packaged DNA. But there is only a small difference in diameter at the top of the channel between pH 7.5 and pH 4.0. Therefore, in addition to acid pH other cellular factors such as proteolytic enzymes likely operate to facilitate capsid dynamic events to externalize these VP1u and VP1/VP2 N-terminal domains and ultimately genome release after trafficking from the early endosome.
A contrast exists between the deployment times of VP1u of some autonomous parvoviruses with that of Parvovirus B19. As noted above VP1u deployment occurs during trafficking through the acidified endosomal compartments. It was found that B19 attachment to human erythrocytes caused early accessibility and activity of PLA2 without entry into a nucleated cell (Bönsch et al., 2008). Thus, VP1u is displayed as the virus remains attached to the surface of erythrocytes. The phospholipase does not cause lysis of the cells but does cause increased osmotic fragility. In an earlier study on VPu of B19 virus, it was reported that the VPu motif is internally oriented but becomes exposed in heat-treated particles and in particles exposed to low pH (Ros et al., 2006).
CPV capsids labeled with fluorescent markers were seen in Rab-5 positive endosomes within minutes of uptake (Harbison et al., 2009). Capsids were also seen in Rab7- and Rab11-positive endosomal compartments by 10-15 minutes after infection. Gradually the virus accumulated near the microtubule organizing center. The CA form of Rab5 induces large, ring-like vesicles in cells and a high proportion of the CPV capsids entered these vesicles and remained there for a period of time of one hour or more. Many of the particles remained attached to the vesicle wall probably in association with the receptors.
In Lepidoptera cells densonucleosis virus (DNV) particles are rapidly internalized and are found in CCVs. They then traffic slowly within early endosomes, then to late endosomes (Vendeville et al., 2009). An alternative route from the endosome is to the multivesicular body (MVB) which contains numerous intraluminal vesicles (ILVs). Fusion of the MVB with the plasma membrane releases small exosomes to the extracellular environment. Exosomes are microvesicles 40-100 nm in size that exhibit a cup-like morphology and appear to be released ILVs (Meckes & Raab-Traub, 2011). The size of an exosome would accomodate one or more parvovirus particles but this pathway would be a detour diverting virus from the entry process leading to nuclear penetration which is essential for virus replication. It is not clear at this time if parvovirus particles are extruded from the cell in exosomes. It would be feasible for cells outside of the viral host range to expel endocytosed particles in this manner, but such a resistance pathway for parvoviruses is yet to be demonstrated.
5. Transition to the late endosome
It is thought that four general biological alterations accompany the early-to-late endosomal transition: acidification of the endosomal lumen, formation of luminal vesicles, the switch of Rab GTPases, and microtubule-mediated transport between the organelles (Greber & Cosset, 2011). Some viruses escape to the cytoplasm under the effects of the acidic environment (pH 6.5 to 6.0) of the early endosome. Sensitivity to endosomal acidification raises a question regarding duration of the virus within the endosome. That is, whether the virus particles are directly released from the early endosomal compartment to the cytosol or are routed farther into the late endocytic compartment or even to the late endosome-lysosome complex. If virus does not escape from the early endosomal station, it would follow the transition pathway to the late endosome. In this transition, the early endosome becomes a transport intermediate recruiting ADP ribosylation factor-1 (Arf1)-dependent coatomer proteins (COPI, clathrin, and AP-1) and converts to the late endosome. Arf 1 or small GTPase’s activities are catalyzed by Sec7-type GTP-exchange factors (GEFs). GEFs are primarily targets of BFA. Therefore, tubulation of maturation of early endosomes is delayed, and virus transition to the late endosome is blocked (Brandenburg et al., 2007; Nebenfuhr et al., 2002; Stuart & Brown, 2006). Studies reported that BFA also affects transport between Golgi and endoplasmic reticulum with the same mechanism through Arf1. BFA was chosen as an inhibitor of pH-dependent endocytosis to investigate early events of murine polyomavirus, SV40, AAV, DNV, MVM, PV, and FCV interaction with the host cell (Blanchard et al., 2006; Damm et al., 2005; Douar et al., 2001; Gilbert & Benjamin, 2004; Guinea & Carrasco, 1995; Mani et al., 2006; Ros et al., 2002; Stuart & Brown, 2006; Vendeville et al., 2009). That BFA blocks infection by these viruses is suggestive of late endosomal involvement in the entry process.
Rab proteins are small GTPases that regulate vesicular transport in endocytosis and exocytosis. They are considered master regulators of transport. Early endosomes are converted to late endosomes as a shift occurs in their linked Rab GTPases from the early endosome-associated Rab5 to the late endosome-associated Rab7 (Cabrera & Ungermann, 2010; Rink et al., 2005; Rodman & Wandinger-Ness, 2000). Rab conversion is the mechanism by which cargo moves from early to late endosomes. The Rab7 domain grows on the early endosome and converts the Rab5-positive endosome to a Rab7-positive endosome (Poteryaev et al., 2010). Participating in this process are the cofactors SAND-1 and Mon1 (Nordmann et al., 2010; Poteryaev et al., 2007). The Rab7 complex is activated by the Class C VPS/HOPS complex (vacuolar protein sorting/homotypic fusion and vacuole protein sorting) complex which is a GEF (guanine nucleotide exchange factor) for Rab7. It interacts with Rab5 and is required for the Rab5 to Rab7 conversion (Rink et al., 2005). Activated Rab5 is important for sequestering ligands into clathrin-coated pits and subsequent fusion of these vesicles with early endosomes. The actin cytoskeleton plays a prominent role in both the early stages of endocytosis and the late Rab5 function (Rodman & Wandinger-Ness, 2000) and actin facilitates fusion among late endosomes and between late endosomes and phagosomes (Kjeken et al., 2004). Materials destined for degradation are delivered to early endosomes then segregated for transport to late endosomes, then to lysosomes (Rodman &Wandinger-Ness, 2000). The transition of the Rab5 early endosome to the Rab 7 late endosome, mediated by the Class C VPS/HOPS complex, is facilitated by Syntaxin-7 which is localized to the late endosome and is required for late endosome and lysosome fusion (Kim et al., 2001). Moreover, the endosomal membrane protein Ema interacts with Class C VPS/HOPS to promote endosomal maturation (Kim et al., 2010).
ADP-ribosylation factor (Arf) in association with Sec7 (Arf GDP/Sec7) is a GEF used in membrane traffic at the Golgi. Arf GDP/Sec7 is phosphorylated to the GTP level which may be used for activation of Class C VPS/HOPS-GDP to Class C VPS/HOPS-GTP that is used in the Rab5 to Rab7 conversion. BFA is a drug with specificity for the Arf-GDP/Sec7 complex and by binding at the interface between Arf-GDP and the Sec7 domains acts as an uncompetitive inhibitor of Arf activation and freezes (stabilizes) the complex that cannot proceed to nucleotide dissociation (Cherfils & Melancon, 2005; Zeghouf et al., 2005). BFA disrupts maturation of the early endosome to the late endosome (Douar et al., 2001; Vieira et al., 2002), but it also interferes with the secretory pathway (Greber & Way, 2006). However, inhibition of parvovirus infection with BFA is not due to interference with the secretory pathway as no parvoviruses are known to exit the infected cell in that way. So, viral susceptibility to BFA in the parvovirus replication cycle is most likely due to blockage of the early-to-late endosome transition. Thus, using BFA inhibition of Arf GTPase employs a strategy for disrupting early to late endosome traffic (Vieira et al., 2002).
A possible mechanism for BFA inhibition of late endosome formation is shown in Fig. 2. Illustrated in the figure is the molecular interaction between the ArfGDP and Sec7 subunits of the ArfGDP/Sec7 GEF complex. This interaction stabilizes the molecular complex preventing its activity as a GEF. Altogether, biochemical and structural data using isolated Sec7 domains provide a consistent explanation for the action of BFA, that its only target is the Arf-GDP/Sec7 interface (Cherfils & Melancon, 2005). This, in turn, inhibits the pathway responsible for the Rab5 to Rab7 conversion which is necessary for endosome maturation. The bovine parvovirus entry pathway goes through clathrin-associated endocytosis (Dudleenamjil et al., 2010) and it may go through extended compartments in this pathway. The results of inhibitor studies using BFA in BPV entry were consistent with virus persistence within the endosome until transition to late endosome is complete (Dudleenamjil & Johnson, unpublished data).
After internalization, generally both virus particles and vesicles that carry virus particles are able to interact with cell cytoskeletal structures and utilize their activities to reach specific sites in the cytoplasm or nucleus for replication. Virus-associated trafficking routes may involve actin filaments together with myosin motors or microtubules with their dynein and kinesin motors. Globular (G-) actin is polymerized to filamentous (F-) actin during synthesis of actin fibers. Synthesis begins with a loose association of three to four G-actin monomers to an unstable oligomer, a process called nucleation. Filaments are then elongated by addition of G-actin monomers. F-actin is involved in both cell movement and in the movement of cell organelles. Endocytic vesicles move at the tips of actin tails and appear to be pushed through the cytosol (Merrifield et al., 1999) and late endosomes can nucleate F-actin whereas early endosomes cannot (Kjeken et al., 2004). LAT A is a natural toxin secreted by red sea sponges, for example
6. Lysosomal interaction
In the viral entry process followed by some non-parvoviruses, exposure of stable capsids to low pH may allow proteolysis of capsid protein to occur creating a metastable configuration displaying sequences for membrane penetration (Cotmore & Tattersall, 2007). CPV enters the cell in association with its receptor, TfR, and the virus along with the TfRs is transported to late endosomes-lysosomes before escape into the cytoplasm (Suikkanen, 2003). In the pathway followed by MVM, a low pH environment fosters proteololysis of the VP2 N-termini which results in enhanced stability at low pH (Cotmore & Tatersall, 2007). Thus, these modified particles may be required to return to a pH-neutral environment before they undergo the structural transition that exposes the PLA2 activity required for membrane penetration. However, it would be expected that after late endosome-lysosome fusion this hazardous compartment would result in extensive viral polypeptide hydrolysis and DNA damage. Results indicate that CPV does not face this same requirement. CPV exposed to low pH
Cells infected with viable parvovirus, empty capsids, or entry-defective mutants accumulate virus in large, crescent-shaped, peri-nuclear vesicular clusters that are probably microtubule organizing centers. The vesicles appear to be late endosomes-lysosomes as the processing of early endosomes to these late structures utilizes microtubule transport. Nocodazole, a microtubule depolymerizing drug, inhibits CPV infection and leaves vesicles containing CPV near the cell surface (Vihinen-Ranta et al., 1998) and they fail to accumulate in the perinuclear crescents. Likewise, in the MVM model, microtubule polymerization moves virus to the perinuclear late endosome-lysosome complex and depolymerization of microtubules scatters virus toward the cell periphery. Upon repolymerization of the microtubules the virus returns to crescent complexes (Cotmore &Tattersall, 2007). Similarly, BPV infection is sensitive to nocodazole treatment.
Some viruses that infect the gastrointestinal tract, notably rotavirus, require proteolytic activation in order to promote virus entry and infection. The proteolytic enzymes in the gastrointestinal tract provide this service to the virus. Influenza A viruses require proteolytic cleavage of the hemagglutinin (H) molecule to separate HA1 and HA2 exposing the fusion peptide located on the N-terminal end of HA2 which is required for bridging the endosomal membrane. Also, the acidic pH of the endosome promotes conformational shift in the HA structure resulting in functional availability of the hydrophobic fusion domain for penetration into the endosomal membrane. Many parvoviruses target the enteric tract and/or the respiratory tract of their natural hosts. Although parvoviruses, many of which may be exposed to the proteolytic enzymes in the gastrointestinal tract or to respiratory proteolysis such as that mediated by tryptase clara, may not require proteolysis for cell entry, but one considers a possible role for proteolysis as well as low pH conformational shifts in capsid protein structure for enhancement of infection relating to the display and activity of the PLA2 and NLS motifs. On the other hand, exposure to low pH may circumvent the infectious pathway. Acid pHs promote virus aggregation and crystal formation (see Fig. 3). The pH of the respiratory tract is acidic resulting from the CO2 reaction with H2O to form carbonic acid. Parvoviruses that infect the respiratory tract such as Parvovirus B19, HuBoV, BPV, AAV and others may aggregate in the respiratory tract. Viruses infecting the gastrointestinal tract such as PPV, MVM, and others may aggregate in the gastric environment. In infected cells, intranuclear newly assembled virions clearly form large crystalline arrays, then, upon escape from the infected cell these newly produced aggregates may not be easily dispersed even at physiological pH. Moreover, regarding entry, it is possible multiple virions may be engulfed in single CCVs and transport together within the endosomal system and upon acidification form aggregates. Because aggregates become too large to penetrate the nucleus as is the case for individual particles, the fate of the virions within the aggregate may not include nuclear entry but they may be digested in the lysosome complex. As demonstrated for PPV, viral aggregates enter by macropinocytosis. The outcome of this pathway may be virus destruction rather than nuclear entry. In this regard, most viral progeny in parvoviral infections may not end up as infectious units but may be cleared and destroyed in the lysosome. More work will be required to decipher the probability of multiple routes of cell entry, and multiple intra-cellular outcomes.
7. Virus escape from endosomes
Paradoxically, parvoviruses must have a capsid shell rugged enough and stable enough to protect their single stranded DNA genomes from damage and degradation during transit from host to host and from portal of entry to ultimate target tissue, yet sensitive enough to navigate the cell-entry process leading to final uncoating within the proper viral replication compartment. Intracellular navigation, in the case of parvoviruses, requires subtle reorientations of capsid structural proteins exposing functional domains on the VP1u motif (Cotmore & Tattersall, 2007). Conceptually, a T=1 virus capsid would be constructed of 60 copies of a structural polypeptide. MVM empty capsids are constructed, on average, of 50 molecules of VP2 and 10 copies of VP1. In parvoviruses, the major (most abundant) structural polypeptide is the smallest structural protein (VP2 or VP3). Altogether, as noted above, the capsids contain either two or three related structural polypeptides that are coterminal at their carboxyterminals and have small unique sequences on their amino terminals. Unique to the larger versions of the polypeptides are elements on the VP1u region that are required for trafficking through the host’s entry pathways (Cotmore & Tattersall, 2007). VP1 is dispensable for capsid assembly and genome packaging, but is absolutely required for infectivity. The VP1u sequence, which is within the N-terminal unique region, contains both the PLA2 phospholipase domain and nuclear localization signals. The proteins are translated from a large mRNA and initiate either by leaky scanning or after differential splicing so that the upstream initiation codon is removed and leaves a downstream codon available for starting translation of the smaller capsid protein. One of these elements, PLA2 which is a lipolytic enzyme is employed to breach the endosomal membrane allowing virus escape from the endocytic organelles, releasing it into the cytosol. An MVMp PLA2 mutant deficient in this enzyme is unable to escape from its vacuolar confine and these particles accumulate in the endosomes. Once the virus is released, the virus targets the nucleus presumably by cellular factors that facilitate transport to the nuclear membrane, penetration across the nuclear membrane, capsid disassembly, exposure of the genome, and movement to an appropriate intranuclear replication compartment. Preliminary capsid conformational change, which may allow eventual endosomal escape, may occur in the early or late endosome but remains to be clarified for the various parvoviruses. It’s likely that parvoviruses as a group utilize their phospholipase activity to escape the endosomal pathway. The parvovirus capsid is structurally dynamic undergoing multiple conformational changes during its replication cycle including the externalization of the VP1 N terminus during entry. In such a condition, VP1 remains tethered to the viral shell and appears to be active in particle escape from the endosome. Interestingly, an active particle may also operate in
When studies use high multiplicities of virus and track the particles in infected cells, many of the particles enter dead-end pathways and never enter the nucleus. Moreover, in cases where ratios of numbers of physical particles to infectious particles have been studied, the ratio is quite high, 300:1 for MVMp and 1000:1 for CPV (Cotmore & Tattersall, 2007). Since only a small number of particles actually arrive at their nuclear destination, it makes the interpretation of vacuolar transport studies that use high viral multiplicities somewhat difficult. Many of these particles may be flagged for destruction and not infection. In studies on BPV entry, virus was labeled with fluorescein, cells exposed to high multiplicities of virus, then observed microscopically over time to assess virus transport through the cell. Labeled virus appeared in vacuolar structures but whether virus was visible in the nucleus was not conclusive (Dudleenamjil & Johnson, unpublished results).
8. Transport to the nucleus and nuclear invasion
In the parvovirus life cycle, structural proteins must be transported at least twice from cytoplasm to the nucleus: following structural protein synthesis so that nuclear capsid assembly can be accommodated and also after virus entry during infection for invasion of the host cell nucleus. Both MVM and CPV have nuclear localization signals (NLS) on their capsid proteins (Cotmore & Tattersall, 2007; Lombardo et al., 2002). Because capsid-associated VP1 undergoes structural rearrangement during entry exposing functional signals, it is possible that the VP1 NLS motif participates in penetration of the invading capsid across the nuclear membrane. Thus, a life-cycle advantage that parvoviruses have over other nuclear-dependent viruses is their small size, small enough at 26 nm to be able to import into the nucleus as an intact (although modified) virion controlled by a bifunctional set of NLS motifs. In support of capsid transport across the nuclear membrane, CPV virions microinjected into cells were found to translocate into the nucleus intact and initiate gene expression (Suikkanen et al., 2003; Vihinen-Ranta et al., 2000). Entry of the microinjected virions circumvented the natural endocytic pathway and placed them in position to penetrate the nucleus, but it is unclear if the NLS motifs were active in the process. As an alternative mechanism of nuclear entry, MVM nuclear penetration in mouse fibroblast cells was tracked by fluorescence microscopy and electron microscopy (Cohen et al., 2006). It was found that this virus caused marked changes in nuclear shape, alterations of nuclear lamin immunostaining and breaks in the nuclear membrane. These changes may allow direct physical access to the nuclear interior for the virus.
Microtubule-associated activity in parvoviral trafficking is involved with dynein-dependent endosomal trafficking of CPV capsids before escape. Further, dynein dependency is seen in movement of CPV capsids after escape through the cytoplasm to the nucleus (Suikkanen, 2003). It was reported that AAV-2 trafficking to the nucleus utilizes the PI13 kinase activation cascade directing virus along microtubules and microfilaments (Sanlioglu et al., 2000). Surprisingly, one study found AAV’s trafficking to the nucleus appears to be independent from the microtubule network (Hirosue et al., 2007). These authors found that overexpression of dynamitin which results in a functional inhibition of the minus-end-directed micotubule motor protein dynein did not inhibit transduction of rAAV2. Treatment of HeLa cells with nocadazole or vinblastine disrupted microtubules but did not significantly affect virus transduction. In contrast, high concentrations of taxol resulted in microtubule stabilization and high vinblastine concentrations caused formation of tubulin paracrystals both reducing rAAV2 transduction. These authors concluded that these results demonstrate that AAV2 can infect HeLa cells independent of dynein function or an intact microtubule network. In another report (Johnson & Samulski, 2009), a population of rAAV2 virions entered the nucleus and accumulated in the nucleolus after infection but empty capsids were excluded from nuclear entry. Interestingly, virions trafficked to the nucleolus were found to retain infectivity in secondary infections. Thus, in the case of AAV, mobilization from the nucleolar site to nucleoplasmic locations likely permits uncoating and gene expression. Also in this study proteosome inhibitors were found to potentiate nucleolar accumulation.
Proteosome activity is essential for PPV infection (Boisvert et al., 2010). In the presence of lactacystin and MG-132, two commonly used proteosome inhibitors, the virus remains in a more diffused state in the perinuclear area of the cell and low-level replication occurs. Supportive data showed that PPV capsid proteins were ubiquitinated early in infection. These observations suggest proteosomal interaction during the last stages of transport prior to nuclear entry. Interaction with the proteosome has also been demonstrated for MVM (Ros et al., 2002; Ros & Kempf, 2004). The exact role for ubiquitination and proteosomal interaction for these viruses remains to be elucidated.
Because the autonomously replicating parvoviruses require the S-phase nuclear environment for replication, after they penetrate the nucleus they remain in a genomic nonsynthetic state until S-phase occurs. The Dependoviruses do not have this constraint as the helper virus provides the synthetic environment, yet these viruses have a constraint of their own, the necessary co-infection with the helper virus. Once in the nucleus, AAV appears to undergo subnuclear mobilization accumulating in the nucleolus (Johnson et al., 2010), uncoating and genome replication. Although the purpose of this review is to only take the entering virus to the intranuclear environment, it is interesting to note that in CPV infection the nuclear replication compartment expands and is accompanied by chromatin marginalization to the vicinity of the nuclear membrane, virus capsids move by passive diffusion, intranuclear structure and dynamics are extensively affected enlarging the interchromosomal domain which contains viral proteins, genomes, and capsids (Ihalainen et al., 2009). After parvovirus assembly and maturation within the nucleus of infected cells, they egress by processes that include apoptosis (Poole et al., 2004; Poole et al., 2006) and cell necrosis (Abdel-Latif et al., 2006).
Not all parvoviruses have been examined in detail for their entry and trafficking pathways, but the model viruses that have been studied reveal some commonalities shared by the viruses in this family. Among these are:
Parvoviruses penetrate their host cell through receptor-mediated endocytosis, interacting with a host cell receptor, and entering in clathrin-coated vesicles.
The viruses are processed in the early to late endosome and possibly lysosome prior to nuclear entry.
In preparation for vacuolar escape, the low pH environment induces capsid protein conformational shifts which display the viral VP1 PLA2 domain and nuclear location signals.
Viral escape from the endosome is mediated by PLA2.
Microtubules and actin generally play a role in virus particle transport to the nuclear membrane where capsid penetration to the intranuclear environment occurs.
Intranuclear mobility occurs by random diffusion for some and for others (AAV) by tracking to the nucleolus.
Alternative pathways may exist for some of these viruses, as seen by macropinocytosis for PPV. There is yet much to be learned about the virus-cell interactions utilized by parvoviruses, mechanisms of bridging the nuclear membrane, intranuclear localization and the uncoating process.
Abdel-Latif L. Murray B. K. Renberg R. L. O’Neill K. L. Porter H. Jensen J. B. Johnson F. B. 2006 Cell death in parvovirus-infected embryonic bovine tracheal cells is mediated by necrosis rather than apoptosis. J. Gen. Virol., 87 9(Sep 2006), 2539 2548, 0022-1317
Abinanti F. R. Warfield M. S. 1961 Recovery of a hemadsorbing virus (HADEN) from the gastrointestinal tract of calves., 14 2(Jun 1961), 288 289, 0042-6822
Agbandje Mc Kenna. M. Chapman M. S. 2006Correlating structure with function in the viral capsid, In: The Parvoviruses, Kerr, J. R., Cotmore, S. F., Bloom, M. E., Linden, R. M., & Parrish, C. R, 125 140, Hodder Arnold, 978-0-34081-198-6London
Agbandje Mc Kenna. M. Llamas-Saiz A. L. Wang F. Tattersall P. Rossmann M. G. 1998 Functional implications of the structure of the murine parvovirus, minute virus of mice. , 6 11(Nov 1998), 1369 1381, 0969-2126
Allander T. Tammi M. T. Eriksson M. Bjerkner A. Tiveljung-Lindell A. Andersson B. 2005 Cloning of a human parvovirus by molecular screening of respiratory tract samples. PNAS, 102 36(Sep 2005), 12891 12896, 1091-6490
Bartlett J. S. Wilcher R. Samulski R. J. 2000 Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors.J. Virol., 74 6(Mar 2000), 2777 2785, 0002-2538X
Basak S. Compans R. W. 1989 Polarized entry of canine parvovirus in an epithelial cell line.J. Virol., 63 7(Jul 1989), 3165 3167, 0002-2538X
Bayer N. Prchla E. Schwab M. Blaas D. Fuchs R. 1999 Human rhinovirus HRV14 uncoats from early endosomes in the presence of bafilomycin. , 463 1(Dec 1999), 175 178, 0014-5793
Beckerle M. C. Porter K. R. 1982 Inhibitors of dynein activity block intracellular transport in erythrophores., 295 5851(Feb 1982), 701 703, 0028-0836
Beer C. Andersen S. D. Rojek A. Pedersen L. 2005 Caveola-dependent endocytic entry of amphotropic murine leukemia virus.J. Virol., 79 16(Aug 2005), 10776 10787, 0002-2538X
Berns K. I. 1990 Parvovirus replication.Microbiol. Mol. Biol. Rev., 54 4(Dec 1990), 316 329, 1092-2172, 1092-2172
Bi Z. Formenty P. B. H. Roth C. E. 2007Human bocavirus, a real respiratory tract pathogen. Afr. J. Microbiol. Res., 1 5(Oct 2007), 051 056, 1996-0808
Blackburn S. D. Cline S. E. Hemming J. P. Johnson F. B. 2005 Attachment of bovine parvovirus to O-linked alpha 2,3 neuraminic acid on glycophorin A. Arch. Virol., 150 7(Jul 2005), 1477 1484, 0304-8608
Blackburn S. D. Steadman R. A. Johnson F. B. 2006 Attachment of adeno-associated virus type 3H to fibroblast growth factor receptor 1. Arch. Virol., 151 3(Mar 2006), 617 623, 0304-8608
Blanchard E. Belouzard S. Goueslain L. Wakita T. Dubuisson J. Wychowski C. Rouille Y. 2006 Hepatitis C virus entry depends on clathrin-mediated endocytosis.J. Virol., 80 14(Jul 2006), 6964 6972, 0002-2538X
Bönsch C. Kemph C. Ros C. 2008 Interaction of Parvovirus B19 human erythrocytes alters virus structure and cell membrane integrity. J.Virol., 82 23(Dec 2008), 11784 11791, 0002-2538X
Boisvert M. Fernandes S. Tijssen P. 2010 Multiple pathways involved in porcine parvovirus cellular entry and trafficking toward the nucleus.J. Virol., 84 15(Aug 2010), 7782 7792, 0002-2538X
Brandenburg B. Lee L. Y. Lakadamyali M. Rust M. J. Zhuang X. Hogle M. J. 2007 Imaging poliovirus entry in live cells. PLoS Biol., 5 7(Jul 2007), 1543 1555, 1544-9173
Brandenburg B. Zhuang X. 2007 Virus trafficking-learning from single-virus tracking. Nat. Rev. Microbiol., 5 3(Mar 2007), 197 208, 1740-1526
Brindley M. A. Maury W. 2008 Equine infectious anemia virus entry occurs through clathrin-mediated endocytosis. J. Virol., 82 4(Feb 2008), 1628 1637, 0002-2538X
Cabrera M. Ungermann C. 2010 Guiding endosomal maturation. , 141 3(Apr 2010), 404 406, 0092-8674
Chapman M. S. Agbandje Mc Kenna. M. 2006Atomic structure of viral particles, In: The Parvoviruses, Kerr, J. R., Cotmore, S. F., Bloom, M. E., Linden, R. M., & Parrish, C. R, 107 124, Hodder Arnold, 978-0-34081-198-6London
Chapman M. S. Rossmann M. G. 1993Structure, sequence, and function correlations among parvoviruses. Virology, 194 2(Jun 1993), 491 508, 0000-0042-6822
Chazal N. Gerlier D. 2003 Virus entry, assembly, budding, and membrane rafts. Microbiol. Mol. Biol. Rev., 67 2(Jun 2003), 226 237, 0000-1092-2172
Chen K. C. Shull B. C. Moses E. A. Lederman M. Stout E. R. Bates R. C. 1986 Complete nucleotide sequence and genome organization of bovine parvovirus.J. Virol., 60 3(Dec 1986), 1085 1097, 0002-2538X
Cherfils J. Melancon P. 2005 On the action of brefeldin A on Sec7-stimulated membrane-recruitment and GDP/GTP exchange of Arf proteins.Biochem. Soc. Trans., 33 Pt4(Jun 2005), 635 638, 0300-5127
Clague M. J. Urbe S. Aniento F. Gruenberg J. 1994 Vacuolar ATPase activity is required for endosomal carrier vesicle formation. J. Biol. Chem., 269 11(Jan 1994), 21 24, 0021-9258
Cohen S. Behzad A. R. Carroll J. B. Pante N. 2006 Parvoviral nuclear import: bypassing the host nuclear-transport machinery.J. Gen. Virol., 87 11(Nov 2006), 3209 3213, 0022-1317
Cotmore S. F. Tattersall P. 2007 Parvoviral host range and cell entry mechanisms. Adv. Virus. Res., 70(2007), 183 232, 0065-3527 10.1016/S0065-3527(07)70005-2
Coue’ M. Brenner S. L. Spector I. Korn E. D. 1987 Inhibition of actin polymerization by latrunculin A.FEBS Lett. 213 2(Mar 1987), 316 318
Damm E. Pelkmans L. 2006Systems biology of virus entry in mammalian cells. Cell. Microbiol., 8 8(Aug 2006), 1219 1227, 1462-5814
Damm E. M. Pelkmans L. Kartenbeck J. Mezzacasa A. Kurzchalia T. Herenius A. 2005 Clathrin- and caveolin-1-independent endocytosis: entry of simian virus 40 into cells devoid of caveolae. J. Cell. Biol., 168 3(Jan 2005), 477 488, 0021-9525
Dawson J. C. Legg J. A. Machesky L. M. 2006Bar domain proteins: a role in tabulation, scission, and actin assembly in clathrin-mediated endocytosis. Trends Cell Biol., 16 10(Oct 2006), 493 498, 0962-8924
De Tulleo L. Kirhchausen T. 1998 The clathrin endocytic pathway in viral infection.The EMBO J., 17 16(Aug 1998), 4585 4593, 0261-4189
Dimitrov D. S. 2004 Virus entry: molecular mechanisms and biomedical applications.Nat. Rev. Microbiol., 2 81(Feb 2004), 111 122, 1740-1526
Di Pasquale G. Chiorini J. A. 2003PKA/PrKX activity is a modulator of AAV/adenovirus interaction. EMBO J., 22 7(Apr 2003), 1716 1724, 0261-4189
Dorsch S. Liebisch G. Kaufmann B. von Landenberg. P. Hoffmann J. H. Drobnik W. Modrow S. 2002 The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity.J. Virol., 76 4(Dec 2002), 2014 2018, 0002-2538X
Douar A. M. Poulard K. Stockholm D. Danos O. 2001 Intracellular trafficking of adeno-associated virus vectors: routing to the late endosomal compartment and proteasome degradation.J.Virol., 75 4(Feb 2001), 1824 1833, 0002-2538X
Doxsey S. J. Brodsky F. M. Blank G. S. Helenius A. 1987 Inhibition of endocytosis by anti-clathrin antibodies. , 50 3(Nov 1987), 453 463, 0000-0092-8674
Drose S. Altendorf K. 1997 Bafilomycins and concanamycins as inhibitors of V-ATPases and P-ATPases. J. Exp. Biol., 200 1(Jan 1997), 1 8, 0022-0949
Dudleenamjil E. Lin-Y C. Dredge D. Murray B. K. Robison R. A. Johnson F. B. 2010 Bovine parvovirus uses clathrin-mediated endocytosis for entry. J.Gen. Virol., 91 12(Dec 2010), 3032 3042, 0022-1317
Eash S. Querbes W. Atwood W. J. 2004 Infection of vero cells by BK virus is dependent on caveolae. J. Virol., 78 21(Nov 2004), 11583 11590, 0002-2538X
Edeling M. A. Smith C. Owen D. 2006 Life of a clathrin coat: insights from clathrin and AP structures.Nat. Rev. Mol. Cell Biol., 7 1(Jan 2006), 32 44, 1471-0072
Farr G. A. Zhang-G L. Tattersall P. 2005 Parvoviral virions deploy a capsid tethered lipolytic enzyme to breach the endosomal membrane during cell entry. PNAS, 102 47(Nov 2005), 17148 17153, 0027-8424
Forest T. Barnard S. Baines J. D. 2005 Active intranuclear movement of herpesvirus capsids.Nat. Cell Biol., 7 4(Apr 2005), 429 431, 1465-7392
Fredericksen B. L. Wei B. L. Yao J. Luo T. Garcia V. J. 2002 Inhibition of endosomal/lysosomal degradation increases the infectivity of human immunodeficiency virus.J. Virol., 76 22(Nov 2002), 11440 11446, 0002-2538X
Freistadt M. S. Eberle K. E. 2006 Fluorescent poliovirus for flow cytometric cell surface binding studies. J. Virol. Methods, 134 1-2, (Jun 2006), 1 7, 0166-0934
Gagescu R. Demaurex N. Parton R. G. Hunziker W. Huber L. A. Gruenberg J. 2000 The recycling endosome of madin-darby canine kidney cells is a mildly acidic compartment rich in raft components.Mol. Biol. Cell, 11 8(Aug 2000), 2775 2791, 1059-1524
Gilbert J. Benjamin T. 2004 Uptake pathway of polyomavirus via ganglioside GD1a. J.Virol., 78 22(Nov 2004), 12259 12267, 0002-2538X
Greber U. F. Cosset F. L. 2011 Too smart to fail-how viruses exploit the complexity of host cells during entry.Curr. Opin.Virol., 1 1(Jul 2011), 3 5, 1879-6257
Greber U. F. Way M. 2006 A superhighway to virus infection. , 124 4(Nov 2006), 741 754, 0092-8674
Guinea R. Carrasco L. 1995 Requirement for vacuolar proton-ATPase activity during entry of influenza virus into cells.J. Virol., 69 4(Apr 1995), 2306 2312, 0002-2538X
Gurda B. L. Parent K. N. Bladek H. Sinkovits R. S. Di Mattia M. A. Rence C. Castro A. Mc Kenna R. Olson N. Brown K. Baker T. S. Agbandje Mc Kenna. M. 2010 Human bocavirus capsid structure: Insights into the structural repertoire of the parvoviridae. J. Virol., 84 12(Jun 2010), 5880 5889, 0002-2538X
Harbison C. E. Chiorini J. A. Parrish C. R. 2008 The parvovirus capsid odyssey: from the cell surface to the nucleus. Trends Microbiol., 16 5(May 2008), 208 214, 0096-6842X
Harbison C. E. Lyi S. M. Weichert W. S. Parrish C. R. 2009 Early steps in cell infection by Parvoviruses: Host-specific differences in cell receptor binding but similar endosomal trafficking. J.Virol., 83 20(Oct 2009), 10504 10514. 0002-2538X
Heuser J. E. Anderson R. G. W. 1989 Hypertonic media inhibit receptor-mediated endocytosis by blocking clathrin-coated pit formation. J. Cell Biol., 108 2(Feb 1989), 389 400, 0021-9525
Hirosue S. Senn K. Clement N. Nonnenmacher M. Gigout L. Linden R. M. Weber . T. 2007 Effect of inhibition of dynein function and microtubule-altering drugs on AAV2 transduction. , 367 1(Oct 2007), 10 18, 0000-0042-6822,
Hommelgaard A. M. Roepstorff K. Vilhardt F. Torgersen M. L. Sandvig K. Deurs B. V. 2005Caveolae: stable membrane domains with a potential for internalization. , 6 9(Sep 2005), 720 724, 1600-0854
Huang F. Khvorova A. Marshall W. Sorkin A. 2004 Analysis of clathrin-mediated endocytosis of epidermal growth factor receptor by RNA interference.J. Biol. Chem., 279 16(Apr 2004), 16657 16661, 0021-9258
Hueffer K. Palermo L. M. Parrish C. R. 2004 Parvovirus infection of cells by using variants of the feline transferrin receptor altering clathrin-mediated endocytosis, membrane domain localization, and capsid-binding domains. J. Virol., 78 11(Jun 2004), 5601 5611, 0002-2538X
Ihalainen T. O. Niskanen E. A. Jylhävä J. Paloheimo O. Dross N. Smolander H. Langowski J. Timonen J. Vihinen-Ranta M. 2009 Parvovirus induced alterations in nuclear architecture and dynamics., 4 6(Jun 2009), 1 16, 1932-6203
Jin M. Park J. Lee S. Park B. Shin J. Song K. J. Ahn T. I. Hwang S. Y. Ahn B. Y. Ahn K. 2002 Hantaan virus enters cells by clathrin-dependent receptor-mediated endocytosis. , 294 1(Mar 2002), 60 69, 0042-6822
Jin S. Zhang B. Weisz O. A. Monteralo R. C. 2005 Receptor-mediated entry by equine infectious anemia virus utilizes a pH-dependent endocytic pathway.J. Virol., 79 23(Dec 2005), 14489 14497, 0002-2538X
Johnson F. B. Fenn L. B. Owens T. J. Faucheux L. J. Blackburn S. D. 2004 Attachment of bovine parvovirus to sialic acids on bovine cell membranes.J. Gen. Virol., 85 8(Aug 2004), 2199 2207, 0022-1317
Johnson F. B. Hoggan M. D. 1973 Structural proteins of HADEN virus., 51 1(Jan 1973), 129 137, 0042-6822
Johnson J. S. Li C. Di Primio N. Weinberg M. S. Mc Cown T. J. Samulski R. J. 2010Mutagenesis of adeno-associated virus type2 capsid protein VP1 uncovers new roles for basic amino acids in trafficking and cell-specific transduction. J. Virol., 84 17(Sep 2010), 8888 8902, 0002-2538X
Johnson J. S. Samulski R. J. 2009 Enhancement of Adeno-associated virus infection by mobilizing capsids into and out of the nucleolus. J. Virol., 83 6(Mar 2009), 2632 2644, 0002-2538X
Kaludov N. Brown K. E. Walters R. W. Zabner J. Chiorini J. A. 2001 Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity. J. Virol., 75 15(Aug 2001), 6884 6893, 0002-2538X
Kaplan N. M. Dove W. Abu Zeid. A. F. Shamoon H. E. Abd-Eldayem S. A. Hart A. C. 2006 Human bocavirus infection among children, Jordan.Emerg. Infect. Dis., 12 9(Sep 2006), 1418 1420, 1080-6040
Kashiwakura Y. Tamayose K. Iwabuchi K. Hirai Y. Shimada T. Matsumoto K. Nakamura T. Watanabe M. Oshimi K. Daida H. 2005 Hepatocyte growth factor receptor is a coreceptor for adeno-associated virus type 2 infection.J. Virol., 79 1(Jan 2005), 609 614, 0002-2538X
Kee S. Cho E. Song J. Park K. S. Baek L. Song K. 2004 Effects of endocytosis inhibitory drugs on rubella virus entry into veroE6 cells.Microbiol. Immunol., 48 11(Dec 2004), 823 829, 0385-5600
Kern A. Schmidt K. Leder C. Műller O. J. Wobus C. E. Bettinger K. Von der Lieth. C. W. King J. A. Kleinschmidt J. A. 2003 Identification of a heparin-binding motif on adeno-associated virus type 2 capsids.J. Virol., 77 20(Oct 2003), 11072 11081, 0002-2538X
Kim B. Y. Kramer H. Yamamoto A. Kominami E. Kohsaka S. Akazawa C. 2001 Molecular characterization of mammalian homologues of class C Vps proteins that interact with Syntaxin-7.J. Biol. Chem., 276 31(Aug 2001), 29393 29402, 0021-9258
Kim S. Waikar Y. P. Daniels R. W. Di Antonio A. 2010 The novel endosomal membrane protein Ema interacts with the class C Vps-HOPS complex to promote endosomal maturation. J. Cell Biol., 188 5(Mar 2010), 717 734, 0021-9525
Kjeken R. Edeberg M. Habermann A. Kuehnel M. Peyron P. Floetenmeyer M. Walther P. Jahrus A. Defacque H. Kuznetsov S. A. Griffiths G. 2004 Fusion between phagosomes, early and late endosomes: a role for actin in fusion between late, but not early endocytic organelles. Mol. Biol. Cell, 15 1(Jan 2004), 345 358, 1059-1524
Krietensson K. Lycre E. Roytta M. Svennerholm B. Vahlne A. 1986Neuritic transport of herpes simplex virus in rat sensory neurons in vitro. Effects of substances interacting with microtubular function and axonal flow [nocodazole, taxol, and erythro-9-3(2-hydroxynonyl)adenine]. J. Gen. Virol., 67 9(Sep 1986), 2023 2028, 0022-1317
Lakadamyali M. Rust M. J. Zhuang X. 2006 Ligands for clathrin-mediated endocytosis are differentially sorted into distinct populations of early endosomes. , 124 5(Mar 2006), 997 1009, 0092-8674
Lecot S. Belouzard S. Dubuisson J. Rouille Y. 2005 Bovine viral diarrhea virus entry is dependent on clathrin-mediated endocytosis.J. Virol, 79 16(Aug 2005), 10826 10829, 0002-2538X
Lemmon S. K. 2001 Clathrin uncoating: Auxilin comes to life.Curr. Biol., 11 2(Jan 2001), R49 R52, 0960-9822
Liebl D. Difato F. Hornikova L. Mannova P. Strokrova J. Forstova J. 2006 Mouse polyomavirus enters early endosomes, requires their acidic pH for productive infection, and meets transferrin cargo in Rab11-positive endosomes. J. Virol., 80 9(May 2006), 4610 4622, 0002-2538X
Lombardo E. Ramirez J. C. Garcia J. Almendral J. M. 2002 Complementary roles of multiple nuclear targeting signals in the capsid proteins of the parvovirus minute virus of mice during assembly and onset infection. J.Virol., 76 14(Jul 2002), 7049 7059, 0002-2538X
Long G. Pan X. Kormelink R. Vlak J. M. 2006 Functional entry of baculovirus into insect and mammalian cells is dependent on clathrin-mediated endocytosis.J. Virol., 80 17(Sep 2006), 8830 8833, 0002-2538X
Ma X. Endo R. Ishiguro N. Ebihara T. Ishiko A. T. Kikuta H. 2006 Detection of human Bocavirus in Japanese children with lower respiratory tract infections. J. Clin. Microbiol., 44 3(Mar 2006), 1132 1134, 0095-1137
Mani B. Baltzer C. Valle N. Almendral J. A. Kempf C. Ros C. 2006 Low pH-dependent endosomal processing of the incoming parvovirus minute virus of mice virion leads to externalization of the VP1 N-terminal sequence (N-VP1), N-VP2 cleavage, and uncoating of the full-length genome.J. Virol., 80 2(Jan 2006), 1015 1024, 0002-2538X
Manteufel J. Truyen U. 2008 Animal bocaviruses: A Brief review. , 51 5(Nov 2008), 328 334, 0300-5526
Marsh M. Helenius A. 2006 Virus entry: Open Sesame. , 124 4(Feb 2006), 729 740, 0092-8674
Meckes D. G. Jr Raab-Traub N. 2011Minireview. Microvesicles and viral infection. J. Virol., 85 24(Dec 2011), 12844 12854, 0002-2538X
Meier O. Boucke K. Hammer S. V. Keller S. Stidwill P. R. Hemmi S. Greber U. F. 2002Adenovirus triggers macropynocytosis and endosomal leakage together with its clathrin-mediated uptake. J. Cell Biol., 158 6(Sep 2002), 1119 1131, 0021-9525
Meier O. Greber U. F. 2004 Adenovirus endocytosis.J. Gene Med, 6 S1(Feb 2004), S152 S163, 0109-9498X
Mercer J. Helenius A. 2009Virus entry by macropynocytosis. Nat. Cell Biol., 11 5(May 2009), 510 520, 1465-7392
Merrifield C. J. Moss S. E. Ballestrem C. Imhof B. A. Giese G. Wunderlich I. Almers W. 1999 Endocytic vesicles move at the tips of actin tails in cultured mast cells.Nat. Cell Biol., 1 1(May 1999), 72 74, 1465-7392
Merrifield C. J. Perrais D. Zenisek D. 2005 Coupling between clathrin-coated pit invagination, contractin recruitment, and membrane scission observed in live cells. , 121 5(May 2005), 593 606, 0092-8674
Nam H. J. Gurda B. L. Mckenna R. Potter M. Byrne B. Salganik M. Muzyczka N. Agbandje Mc Kenna. M. 2011 Structural studies of Adeno-associated virus serotype 8 capsid transitions associated with endosomal trafficking. J. Virol., 85 22(Nov 2011), 11791 11799, 0002-2538X
Nebenfuhr A. Ritsenthaler C. Robinson D. G. 2002 Brefeldin A: deciphering an enigmatic inhibitor of secretion. Plant Physiol., 130 3(Nov 2002), 1102 1108, 0032-0889
Nordmann M. Cabrera M. Perz A. Brocker C. Ostrowicz C. Engelbrecht-Vandre . S. Undermann C. 2010The Mon1-Ccz1 complex is the GEF of the late endosomal Rab7 homolog Ypt. Curr. Biol., 20 18(Aug 2010), 1654 1659, 0000-0960-9822
Op De Beeck. A. Caillet-Fauquet P. 1997 Viruses and the cell cycle.Prog. Cell Cycle Res., 3 1(1997), 1 19, 1087-2957
Palermo L. M. Hafenstein S. L. Parrish C. R. 2006Purified feline and canine transferrin receptors reveal complex interactions with the capsid of Canine and Feline Parvoviruses that correspond to their host ranges. J. Virol., 80 17(Sep 2006), 8482 8492, 0002-2538X
Parker J. S. L. Murphy W. J. Wang D. O’Brien S. J. Parrish C. R. 2001 Canine and feline parvoviruses can use human or feline transferrin receptors to bind, enter, and infect cells. J. Virol., 75 8(Apr 2001), 3896 3902, 0002-2538X
Parker J. S. Parrish C. R. 2000 Cellular uptake and infection by canine parvovirus involves rapid dynamin-regulated clathrin-mediated endocytosis, followed by slower intracellular trafficking. J. Virol., 74 4(Feb 2000), 1919 1930, 0000-0022-538X
Pelkmans L. 2005a Secrets of caveolae- and lipid raft-mediated endocytosis revealed by mammalian viruses. Biochim. Biophys. Acta, 1746 3(Dec 2005), 295 304, 0006-3002
Pelkmans L. 2005b Viruses as probes for systems analysis of cellular signaling, cytoskeleton reorganization, and endocytosis.Curr. Opin. Microbiol., 8 3(Jun 2005), 331 337, 1369-5274
Pelkmans L. Helenius A. 2003 Insider information: what viruses tell us about endocytosis.Curr. Opin. Cell Biol., 15 4(Aug 2003), 414 422, 0000-0955-0674
Pelkmans L. Burli T. Zerial M. Helenius A. 2004 Caveolin-stabilized membrane domains as multifunctional transport and sorting devices in endocytic membrane traffic., 118 6(Sep 2004), 767 780, 0092-8674
Pelkmans L. Fava E. Grabner H. Hannus M. Habermann B. Krausz E. Zerial M. 2005 Genome-wide analysis of human kinases in clathrin- and caveolae/raft-mediated endocytosis., 436 7(Jul 2005), 78 86, 0028-0836
Poole B. D. Karetnyi Y. V. Naides S. J. 2004 Parvovirus B19-induced apoptosis of hepatocytes.J. Virol., 78 14(Jul 2004), 7775 7783, 0002-2538X
Poole B. D. Zhou J. Grote A. Shiffenbauer A. Naides S. J. 2006 Apoptosis of liver-derived cells induced by parvovirus B19 nonstructural protein.J. Virol., 80 8(Apr 2006), 4114 4121, 0002-2538X
Poteryaev D. Datta D. Ackema K. Zerial M. Sprang A. 2010 Identification of the switch in early-to-late endosome transition. , 141 3(Apr 2010), 497 508, 0092-8674
Poteryaev D. Fares H. Bowerman B. Sprang A. 2007Caenorhabditis elegans SAND-1 is essential for RAB-7 functionis endosomal traffic. EMBO J., 26 2(Jan 2007), 301 312, 0261-4189
Pu Y. Zhang X. 2008Mouse Hepatitis Virus Type 2 enters cells through a clathrin-mediated endocytosis pathway independent of Eps15Δ. J. Virol., 82 16(Aug 2008), 8112 8123, 0002-2538X
Qing K. Mah C. Hansen J. Zhou S. Dwarki V. Srivastava A. 1999Human fibroblast growth factor receptor 1 is a coreceptor for infection by adeno-associated virus 2. Nat. Med., 5 1(Jan 1999), 71 78
Qiu J. Cheng F. Johnson B. F. Pintel D. 2007 The transcription profile of the Bocavirus bovine parvovirus is unlike those of previously characterized parvoviruses.J. Virol., 81 21(Nov 2007), 12080 12085, 0002-2538X
Qiu J. Handa A. Kirby M. Brown K. E. 2000 The interaction of heparin sulfate and adeno-associated virus 2., 269 1(Mar 2000), 137 147, 0042-6822
Ramanathan H. Jonsson C. B. 2008 New and old world hantaviruses differentially utilize host cytoskeletal components during their life cycles. , 374 1(Apr 2008), 138 150, 0042-6822
Rink J. Ghigo E. Kalaidzidis Y. Zerial M. 2005Rab conversation as a mechanism of progression from early to late endosomes. Cell, 122 5(Sep 2005), 735 749, 0092-8674
Rodman J. S. Wandinger-Ness A. 2000 Rab GTPases coordinate endocytosis.J. Cell Sci., 113 Pt2(Jan 2000), 183 192, 0021-9533
Ros C. Burckhardt C. J. Kempf C. 2002 Cytoplasmic trafficking of minute virus of mice: Low-pH requirement, routing to late endosomes and proteasome interaction.J. Virol, 76 24(Dec 2002), 12634 12645, 0002-2538X
Ros C. Gerber M. Kempf C. 2006Conformational changes in the VP1-unique region of native human parvovirus B19 lead to exposure of internal sequences that play a role in virus internalization and infectivity. J. Virol., 80 24(Dec 2006), 12017 12024, 0002-2538X
Ros C. Kempf C. 2004 The ubiquitin-proteasome machinery is essential for nuclear translocation of incoming minute virus of mice., 324 2(Jul 2004), 350 360, 0042-6822
Russell M. R. G. Nickerson D. P. Odorozzi G. 2006 Molecular mechanisms of late endosome morphology, identity, and sorting. Curr. Opin. Cell. Biol., 18 4(Aug 2006), 422 428, 0955-0674
Sandals W. C. D. Rovey R. C. Meek A. H. 1995 Prevalence of bovine parvovirus in Ontario dairy cattle. Can. J.Vet. Res., 59 2(Apr 1995), 81 86, 0830-9000
Sanlioglu S. Benson P. K. Yang J. Atkinson E. M. Reynolds T. Engelhardt J. F. 2000 Endocytosis and nuclear trafficking of Adeno-associated virus type 2 are controlled by Rac1 and phosphatidylinositol-3 kinase activation.J. Virol., 74 19(Oct 2000), 9184 9196, 0002-2538X
Shull B. C. Chen K. C. Lederman M. Stout E. R. Bates R. C. 1988 Genomic clones of bovine parvovirus: construction and effect of deletions and terminal sequence inversions on infectivity.J. Virol., 62 2(Feb 1988), 417 426, 0000-0022-538X
Sieczkarski S. B. Brown H. A. Whittaker G. R. 2003 Role of protein kinase C ßII in influenza virus entry via late endosomes. J. Virol., 77 1(Jan 2003), 460 469, 0002-2538X
Sieczkarski S. B. Whittaker G. R. 2002 Dissecting virus entry via endocytosis.J. Gen. Virol., 83 7(Jul 2002), 1535 1545, 0022-1317
Simpson A. A. Chandrasekar V. Hẻbert B. Sullivan G. M. Rossmann M. G. Parrish C. R. 2000 Host range and variability of calcium binding by surface loops in the capsids of Canine and Feline Parvoviruses. J. Mol. Biol., 300 3(Jul 2000), 597 610, 0022-2836
Smart E. J. Foster D. C. Ying Y. S. Kamen B. A. Anderson R. G. W. 1994 Protein kinase C activators inhibit receptor-mediated potocytosis by preventing internalization of caveolae. J. Cell Biol., 124 3(Feb 1994), 307 313, 0021-9525
Smith A. E. Helenius A. 2004 How viruses enter animal cells.Sci., 304 9(Apr 2004), 237 241, 0036-8075
Sonntag F. Bleker S. Leuchs B. Fischer R. Kleinschmidt J. A. 2006 Adeno-associated virus type 2 capsids with externalized VP1/VP2 trafficking domains are generated prior to passage through the cytoplasm and are maintained until uncoating occurs in the nucleus.J. Virol., 80 22(Nov 2006), 11040 11054, 0002-2538X
Stidwill R. P. Greber U. F. 2000 Intracellular virus trafficking reveals physiological characteristics of the cytoskeleton.News Physiol. Sci, 15 2(Apr 2000), 67 71, 0886-1714
Stuart A. D. Brown D. K. T. 2006 Entry of feline calicivirus is dependent on clathrin-mediated endocytosis and acidification in endosomes.J. Virol., 80 15(Aug 2006), 7500 7509, 0002-2538X
Suikkanen S. 2003 Cell biology of canine parvovirus entry, Jan 11, 2012, Available from:< https://jyx.jyu.fi/dspace/bitstream/handle/123456789/13139/9513917851.pdf?sequence=1>
Suikkanen S. Antila M. Jaatinen A. Vihinen-Ranta M. Vuento M. 2003 Release of canine parvovirus from endocytic vesicles., 316 2(Nov 2003), 267 280, 0042-6822
Summerford C. Bartlett J. S. Samulski R. J. 1999AlphaVbeta5 intergin: a co-receptor for adeno-associated virus type 2 infection. Nat. Med., 5 1(Jan 1999), 78 82, 1078-8956
Summerford C. Samulski R. J. 1998Membrane-associated heparin sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J. Virol., 72 2(Feb 1998), 1438 1445, 0002-2538X
Sun T. X. Hoek A. V. Huang Y. Bouley R. Mc Laughlin M. Brown D. 2002 Aquaporin-2 localization in clathrin-coated pits: inhibition of endocytosis by dominant-negative dynamin.Am. J. Physiol. Renal Physiol., 282 6(Jun 2002), F998 F1011, 0193-1857X
Sun Y. Chen A. Y. Cheng F. Guan W. Johnson F. B. Qiu J. 2009 Molecular characterization of infectious clones of the minute virus canines reveals unique features of bocaviruses. J.Virol., 83 8(Apr 2009), 3956 3967, 0002-2538X
Thacker T. C. Johnson F. B. 1998 Binding of bovine parvovirus to erythrocyte membrane sialylglycoproteins.J. Gen. Virol., 79 9(Sep 1998), 2163 2169, 0022-1317
Tomita M. Furthmayr H. Marchesi V. T. 1978 Primary structure of human erythrocyte glycophorin A. Isolation and characterization of peptides and complete amino acid sequence., 17 22(Oct 1978), 4756 4770
Tsao J. Chapman M. S. Agbandje M. Keller W. Smith K. Wu H. Luo M. Smith T. J. Rossmann M. G. Compans R. W. Parrish C. R. 1991 The three-dimensional structure of canine parvovirus and its functional implications.Sci, 251 5000(Mar 1991), 1456 1464, 0036-8075
Van der Goot F. G. Gruenberg J. 2006 Intra-endosomal membrane traffic. Trends Cell Biol., 16 10(Oct 2006), 514 521, 0962-8924
Vendeville A. Ravallec M. Jousset F. X. Devise M. Mutuel D. Lopez-Ferber M. Fournier P. Dupressoir T. Ogliastro M. 2009 Densovirus infectious pathway requires clathrin-mediated endocytosis followed by trafficking to the nucleus. J. Virol., 83 9(May 2009), 4678 4689, 0002-2538X
Viera O. V. Botelho R. J. Grinstein S. 2002Phagosome maturation: aging gracefully. Biochem. J., 366 Pt3(Sep 2002), 689 704, 0264-6021
Vihinen-Ranta M. Kalela A. Makinen P. Kakkola L. Marjomaki V. Vuento M. 1998 Intracellular route of canine parvovirus entry. J. Virol., 72 1(Jan 1998), 802 806, 0002-2538X
Vihinen-Ranta M. Wang D. Weichert W. S. Parrish C. R. 2002 The VP1 N-terminal sequence of canine parvovirus affects nuclear transport of capsids and efficient cell infection.J. Virol., 76 4(Feb 2002), 1884 1891, 0002-2538X
Vihinen-Ranta M. Yuan W. Parrish C. R. 2000 Cytoplasmic trafficking of the Canine Parvovirus capsid and its role in infection and nuclear transport. J. Virol., 74 10(May 2000), 4853 4859, 0002-2538X
Walters R. W. Yi S. M. P. Keshavjee S. Brown K. E. Welsh M. J. Chiorini J. A. Zabner J. 2001 Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer.J. Biol. Chem., 276 23(Mar 2001), 20610 20616, 0021-9258
Wassmer T. Froissard M. Plattner H. Kissmehl R. Cohen J. 2005 The vacuolar proton-ATPase plays a major role in several membrane-bounded organelles in Paramecium.J. Cell. Sci., 118 13(Jul 2005), 2813 2825, 0021-9533
Yarmola E. G. Somasundaram T. Boring T. A. Spector I. Bubb M. R. 2000Actin-latrunculin A structure and function. J. Biol. Chem., 275 36(Sept 2000), 28120 28127
Yuan W. Parrish C. R. 2001 Canine parvovirus capsid assembly and differences in mammalian and insect cells. , 279 2(Jan 2001), 546 557, 0042-6822
Zeghouf M. Guibert B. Zeeh-C J. Cherfils J. 2005 Arf, Sec7, and brefeldin A: a model towards the therapeutic inhibition of guanine nucleotide-exchange factors. Biochem. Soc. Trans., 33 Pt6(Dec 2005), 1265 1268, 0300-5127